Skip to main content

Incyte to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:

  • Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 10:00 am (EST)
  • Jefferies Global Healthcare Conference (London) on Tuesday, November 18, 2025 at 11:00 am (GMT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.45
-1.86 (-0.71%)
AAPL  310.03
+4.44 (1.45%)
AMD  484.39
-21.61 (-4.27%)
BAC  64.23
+0.34 (0.53%)
GOOG  341.28
-0.17 (-0.05%)
META  543.67
-25.30 (-4.45%)
MSFT  481.63
+1.28 (0.27%)
NVDA  219.74
-5.27 (-2.34%)
ORCL  142.79
-3.86 (-2.63%)
TSLA  336.87
-2.43 (-0.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.